244 related articles for article (PubMed ID: 33121329)
1. Product review of the rotavirus vaccines ROTASIIL, ROTAVAC, and Rotavin-M1.
Skansberg A; Sauer M; Tan M; Santosham M; Jennings MC
Hum Vaccin Immunother; 2021 Apr; 17(4):1223-1234. PubMed ID: 33121329
[TBL] [Abstract][Full Text] [Related]
2. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Bergman H; Henschke N; Hungerford D; Pitan F; Ndwandwe D; Cunliffe N; Soares-Weiser K
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD008521. PubMed ID: 34788488
[TBL] [Abstract][Full Text] [Related]
3. Established and new rotavirus vaccines: a comprehensive review for healthcare professionals.
Vetter V; Gardner RC; Debrus S; Benninghoff B; Pereira P
Hum Vaccin Immunother; 2022 Dec; 18(1):1870395. PubMed ID: 33605839
[TBL] [Abstract][Full Text] [Related]
4. Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?
Deen J; Lopez AL; Kanungo S; Wang XY; Anh DD; Tapia M; Grais RF
Hum Vaccin Immunother; 2018 Feb; 14(2):495-499. PubMed ID: 29135339
[TBL] [Abstract][Full Text] [Related]
5. The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease.
Glass RI; Tate JE; Jiang B; Parashar U
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S331-S342. PubMed ID: 34590142
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial.
Kanungo S; Chatterjee P; Bavdekar A; Murhekar M; Babji S; Garg R; Samanta S; Nandy RK; Kawade A; Boopathi K; Kanagasabai K; Kamal VK; Kumar VS; Gupta N; Dutta S
Lancet Infect Dis; 2022 Aug; 22(8):1191-1199. PubMed ID: 35588754
[TBL] [Abstract][Full Text] [Related]
7. Global Experience With Rotavirus Vaccines.
Burke RM; Tate JE; Parashar UD
J Infect Dis; 2021 Dec; 224(12 Suppl 2):S792-S800. PubMed ID: 34374426
[TBL] [Abstract][Full Text] [Related]
8. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A
Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039
[TBL] [Abstract][Full Text] [Related]
9. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants.
Ella R; Babji S; Ciarlet M; Blackwelder WC; Vadrevu KM
Vaccine; 2019 Jul; 37(31):4407-4413. PubMed ID: 31178377
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of two formulations of rotavirus vaccine in Vietnamese infants.
Thiem VD; Anh DD; Ha VH; Hien ND; Huong NT; Nga NT; Thang TC; McNeal MM; Meyer N; Pham HL; Huong NM; Gompana G; Cassels F; Tang Y; Flores J; Rathi N
Vaccine; 2021 Jul; 39(32):4463-4470. PubMed ID: 34218961
[TBL] [Abstract][Full Text] [Related]
11. Effect of rotavirus genetic diversity on vaccine impact.
Sadiq A; Bostan N; Jadoon Khan ; Aziz A
Rev Med Virol; 2022 Jan; 32(1):e2259. PubMed ID: 34997676
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of rotavirus gastroenteritis and need of high rotavirus vaccine coverage with early completion of vaccination schedule for protection against rotavirus diarrhea in India: A narrative review.
Raju B; Parikh RP; Vetter VV; Kolhapure S
Indian J Public Health; 2019; 63(3):243-250. PubMed ID: 31552856
[TBL] [Abstract][Full Text] [Related]
13. Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines.
Debellut F; Tang K; Clark A; Pecenka C; Assao B; Guindo O; Grais RF; Isanaka S
BMJ Open; 2022 Oct; 12(10):e061673. PubMed ID: 36198460
[TBL] [Abstract][Full Text] [Related]
14. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children.
Dang DA; Nguyen VT; Vu DT; Nguyen TH; Nguyen DM; Yuhuan W; Baoming J; Nguyen DH; Le TL;
Vaccine; 2012 Apr; 30 Suppl 1():A114-21. PubMed ID: 22520120
[TBL] [Abstract][Full Text] [Related]
15. Diversity of rotavirus genotypes circulating in children < 5 years of age hospitalized for acute gastroenteritis in India from 2005 to 2016: analysis of temporal and regional genotype variation.
Giri S; Kumar CPG; Khakha SA; Chawla-Sarkar M; Gopalkrishna V; Chitambar SD; Ray P; Venkatasubramanian S; Borkakoty BJ; Roy S; Bhat J; Dwibedi B; Das P; Paluru V; Ramani S; Babji S; Arora R; Mehendale SM; Gupte MD; Kang G;
BMC Infect Dis; 2020 Oct; 20(1):740. PubMed ID: 33036575
[TBL] [Abstract][Full Text] [Related]
16. Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi.
Niyibitegeka F; Riewpaiboon A; Youngkong S; Thavorncharoensap M
Vaccine; 2021 Feb; 39(8):1272-1282. PubMed ID: 33487467
[TBL] [Abstract][Full Text] [Related]
17. Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines.
Lepage P; Vergison A
Expert Opin Biol Ther; 2007 Dec; 7(12):1881-92. PubMed ID: 18034653
[TBL] [Abstract][Full Text] [Related]
18. Rotavirus vaccines: progress and new developments.
Cates JE; Tate JE; Parashar U
Expert Opin Biol Ther; 2022 Mar; 22(3):423-432. PubMed ID: 34482790
[TBL] [Abstract][Full Text] [Related]
19. Rotavirus vaccine: a cost effective control measure for India.
Kumar A; Goel MK; Jain RB; Khanna P; Vibha V
Hum Vaccin Immunother; 2012 Apr; 8(4):501-4. PubMed ID: 23071989
[TBL] [Abstract][Full Text] [Related]
20. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2012 Nov; 11():CD008521. PubMed ID: 23152260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
